Sangamo Biosciences, Inc. (SGMO) Tops Q4 EPS by 5c, Guides FY Rev

February 6, 2013 4:10 PM

Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q4 EPS of ($0.07), $0.05 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found